# Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

> **NCT02825576** · PHASE4 · TERMINATED · sponsor: **Northern Sydney Anaesthesia Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Pulmonary Complications

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine/Glycopyrrolate

## Key facts

- **NCT ID:** NCT02825576
- **Lead sponsor:** Northern Sydney Anaesthesia Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-03
- **Primary completion:** 2020-04-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Lack of Study Personnel
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825576, "Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02825576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*